Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA is seeking information on industry capabilities for providing real-time signals to enhance post-market surveillance of regulated products. This RFI aims to gather insights on potential technical integration and cost models, but it is not a solicitation for proposals.
The U.S. Food and Drug Administration (FDA) is conducting market research to better understand industry capabilities related to providing real-time or near-real-time signals that may support FDAs post-market surveillance activities for regulated products. FDA is interested in learning whether commercial organizations currently provide, or could provide, timely signals or alerts related to events affecting regulated products, such as safety events, product quality issues, supply disruptions, or other significant public health signals. Information obtained through this Request for Information (RFI) will assist the Government in determining the availability of industry capabilities, potential technical integration approaches, and possible cost models associated with providing real-time signal feeds to FDA systems. This RFI is issued for market research purposes only and does not constitute a solicitation for proposals or a commitment by the Government to issue a solicitation in the future.
Real-Time Post-Market Signal For Enhanced Surveillance is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.